Archives

  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10

    • Influenza Hemagglutinin (HA) Peptide: High-Purity Epitope...

    2026-04-08

    Influenza Hemagglutinin (HA) Peptide: High-Purity Epitope Tag for Protein Detection and Purification

    Executive Summary: The Influenza Hemagglutinin (HA) Peptide (sequence: YPYDVPDYA) is a synthetic nine-amino-acid tag derived from the influenza virus hemagglutinin protein and is widely used in molecular biology as an epitope tag for the detection and purification of HA-tagged fusion proteins [APExBIO]. It enables competitive binding to anti-HA antibodies, facilitating efficient elution in immunoprecipitation workflows [LabPe]. The peptide exhibits high purity (>98%) verified by HPLC and mass spectrometry, with robust solubility in DMSO (≥55.1 mg/mL), ethanol (≥100.4 mg/mL), and water (≥46.2 mg/mL) [APExBIO]. Proper storage at -20°C in a desiccated state preserves its functional integrity [Perylene-Azide]. This review delineates the biological rationale, mechanistic action, benchmark evidence, and integration best practices for the HA tag peptide in advanced protein science.

    Biological Rationale

    The Influenza Hemagglutinin (HA) Peptide serves as a minimal, defined epitope derived from the hemagglutinin protein of human influenza virus (YPYDVPDYA). The HA tag is recognized specifically and with high affinity by anti-HA monoclonal antibodies, enabling selective detection and isolation of HA-tagged proteins in recombinant expression systems [Wei et al., 2021]. This approach circumvents the need for protein-specific antibodies, streamlining workflows and improving reproducibility in immunoprecipitation (IP), western blotting, and protein-protein interaction studies [Hemagglutinin-Precursor]. The HA tag system is widely adopted due to its small size (9 amino acids), minimizing steric hindrance and functional perturbation of target proteins.

    Mechanism of Action of Influenza Hemagglutinin (HA) Peptide

    The HA tag peptide functions as a competitive epitope, binding to anti-HA antibodies with high specificity. In immunoprecipitation assays, excess free HA peptide (YPYDVPDYA) is introduced to competitively displace HA-tagged fusion proteins from antibody-bound beads or matrices, enabling their elution under mild, non-denaturing conditions [LabPe]. This competitive elution preserves native protein complexes and post-translational modifications, which can be disrupted by harsh chemical elution methods. The HA peptide's compatibility with various solvents (DMSO, ethanol, water) and its stability at -20°C facilitate its use in diverse laboratory settings. The binding affinity between the HA tag and the monoclonal antibody is typically in the nanomolar range, ensuring specificity and low background [Perylene-Azide].

    Evidence & Benchmarks

    • HA-tagged constructs enable robust detection and purification of target proteins in diverse mammalian and non-mammalian systems (Wei et al., 2021, https://doi.org/10.1038/s41422-020-00409-1).
    • High-purity (>98%) synthetic HA peptide, such as that provided by APExBIO, yields reproducible results in immunoprecipitation and protein interaction studies (APExBIO product page).
    • HA peptide elution preserves multi-protein complexes and protein activity more effectively than low-pH or denaturing elution buffers (LabPe, https://labpe.com/index.php?g=Wap&m=Article&a=detail&id=209).
    • Solubility benchmarks: ≥55.1 mg/mL in DMSO, ≥100.4 mg/mL in ethanol, ≥46.2 mg/mL in water (APExBIO, product data).
    • HA tag sequence does not disrupt protein folding or function in most recombinant constructs (Hemagglutinin-Precursor).

    Applications, Limits & Misconceptions

    The HA tag peptide system is optimized for:

    • Competitive elution of HA-tagged fusion proteins from immunoprecipitation matrices (Anti-HA Magnetic Beads, agarose, etc.).
    • Protein detection in western blotting, immunofluorescence, and ELISA.
    • Quantitative protein-protein interaction and post-translational modification analysis.
    • Workflow optimization in translational research and high-throughput screening [Peptone-Bacteriological].

    For a more detailed breakdown of the peptide’s workflow applications and recent advances in competitive elution, see Optimizing Protein Interaction Assays with Influenza Hemagglutinin (HA) Peptide, where practical integration strategies are discussed. This article extends that discussion by adding quantitative purity and solubility benchmarks and updated evidence from recent peer-reviewed studies.

    Common Pitfalls or Misconceptions

    • Not a universal tag: The HA tag peptide is not suitable for all protein expression systems, particularly those with endogenous anti-HA antibody cross-reactivity.
    • Not for in vivo therapeutic use: It is strictly for research use only; not validated for clinical or therapeutic purposes.
    • Not compatible with all antibodies: Only validated monoclonal or polyclonal anti-HA antibodies efficiently bind the YPYDVPDYA sequence.
    • Stability limits: Long-term storage of peptide solutions (especially above -20°C or in aqueous buffers) leads to degradation and loss of activity.
    • No endogenous biological activity: The HA peptide does not exhibit intrinsic signaling or biological effects outside its role as an epitope tag.

    For further clarification on these boundaries, compare with Influenza Hemagglutinin (HA) Peptide: Precision Tag for Protein Detection, which covers fundamental tag attributes but does not address solution stability or antibody-specificity limitations as in this article.

    Workflow Integration & Parameters

    For optimal use, dissolve the lyophilized HA peptide in DMSO (≥55.1 mg/mL), ethanol (≥100.4 mg/mL), or water (≥46.2 mg/mL) according to experimental requirements. Store aliquots desiccated at -20°C to prevent hydrolytic degradation. During immunoprecipitation, use a final peptide concentration of 1–2 mg/mL for competitive elution, adjusting as necessary for bead capacity and target protein abundance. Avoid repeated freeze-thaw cycles. The high purity (>98% by HPLC and MS) offered, for instance, by APExBIO, ensures minimal background and maximal reproducibility [Product page]. For advanced workflows, the HA peptide can be integrated into multiplexed IP or co-immunoprecipitation setups, provided antibody compatibility is verified in advance.

    For technical comparisons on protein interaction analysis and advanced elution strategies, see Influenza Hemagglutinin (HA) Peptide: Elevating Precision in Protein Purification, which reviews unique mechanisms relevant to cancer research, extending the practical focus of this article with mechanistic details.

    Conclusion & Outlook

    The Influenza Hemagglutinin (HA) Peptide, as exemplified by APExBIO's A6004 product, remains a cornerstone tool for protein tagging, detection, and immunoprecipitation in molecular biology. Its high purity, strong specificity, and compatibility with a range of biochemical techniques support robust, reproducible experimental outcomes. Ongoing advances in antibody development and workflow automation are expected to further expand the utility of the HA tag system in proteomics, interactomics, and translational research.

    For technical specifications or ordering information, visit the official Influenza Hemagglutinin (HA) Peptide (A6004) product page.